The online submission platform for ERDERA’s Joint Transnational Call 2025 is now live

We are pleased to announce that the platform for submitting project applications for the Joint Transnational Call for Proposals (JTC) 2025 is now officially live. This highly anticipated call invites research teams across Europe and internationally to collaborate on cutting-edge projects aimed at “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation.” 

How to Use the Platform 

The platform will allow you to: 

  • Register and provide all required personal data for project participants. 
  • Enter your finalised project description.

Access to the platform can be found here.

We strongly recommend registering early to familiarise yourself with the platform’s functionality. A template outlining the required data is available on the ERDERA Funding webpage to assist in your preparation. 

Application Timeline  

The JTC 2025 will follow a two-stage submission process:  

  • 13 February 2025: Pre-proposal submission deadline.  
  • 9 July 2025: Full proposals submission deadline.  

Funding decisions are expected by December 2025. 

For further details, access the updated call documents here. 

News & Updates

You might also be interested in

November 25 @ 1:00 pm - 2:00 pm
Intended for clinicians, clinical geneticists, researchers, data analysts and ERN members working in rare diseases
Horizon Europe’s 2026–2027 work programme combines broad health research opportunities with changes to applications and new support for taking existing results further.
ERDERA’s third General Assembly brought partners together in Coimbra to review its second year, strengthen connections across the partnership and align priorities for a more integrated and delivery-focused third year.
ERDERA marked the close of its second year with an Open Session on ultra-rare diseases, bringing together European, regulatory and scientific perspectives on how innovation can reach patients.